ProKidney Corp (NASDAQ:PROK) shares, rose in value on Wednesday, February 12, with the stock price down by -0.65% to the previous day’s close as strong demand from buyers drove the stock to $1.54.
Actively observing the price movement in the last trading, the stock closed the session at $1.55, falling within a range of $1.51 and $1.58. The value of beta (5-year monthly) was 1.305. Referring to stock’s 52-week performance, its high was $4.44, and the low was $1.18. On the whole, PROK has fluctuated by -6.67% over the past month.
With the market capitalization of ProKidney Corp currently standing at about $449.23 million, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that PROK’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of PROK currently trading nearly -5.70% and -11.33% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.54, while the 7-day volatility ratio is showing 5.63% which for the 30-day chart, stands at 7.63%. Furthermore, ProKidney Corp (PROK)’s beta value is 1.43, and its average true range (ATR) is 0.12.
A comparison of ProKidney Corp (PROK) with its peers suggests the former has fared considerably weaker in the market. PROK showed an intraday change of -0.65% in last session, and over the past year, it grew by 26.23%%.
Data on historical trading for ProKidney Corp (NASDAQ:PROK) indicates that the trading volumes over the past 10 days have averaged 0.33 and over the past 3 months, they’ve averaged 447.69K. According to company’s latest data on outstanding shares, there are 127.92 million shares outstanding.
Nearly 28.61% of ProKidney Corp’s shares belong to company insiders and institutional investors own 44.06% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.88 million shares as on 2025-01-31, resulting in a short ratio of 25.62. According to the data, the short interest in ProKidney Corp (PROK) stood at 1016.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 10.65 million. The stock has fallen by -8.88% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the PROK stock heading into the next quarter.
